164 related articles for article (PubMed ID: 12431993)
1. Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides.
Macris MA; Glazer PM
J Biol Chem; 2003 Jan; 278(5):3357-62. PubMed ID: 12431993
[TBL] [Abstract][Full Text] [Related]
2. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment.
Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C
Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289
[TBL] [Abstract][Full Text] [Related]
3. Activation of gene expression by triplex-directed psoralen crosslinks.
Song J; Intody Z; Li M; Wilson JH
Gene; 2004 Jan; 324():183-90. PubMed ID: 14693383
[TBL] [Abstract][Full Text] [Related]
4. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells.
Vasquez KM; Wang G; Havre PA; Glazer PM
Nucleic Acids Res; 1999 Feb; 27(4):1176-81. PubMed ID: 9927753
[TBL] [Abstract][Full Text] [Related]
7. Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides.
Vasquez KM; Dagle JM; Weeks DL; Glazer PM
J Biol Chem; 2001 Oct; 276(42):38536-41. PubMed ID: 11504712
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of ICAM-1 expression mediated by gene targeting with Triplex-forming oligonucleotides.
Besch R; Giovannangeli C; Kammerbauer C; Degitz K
J Biol Chem; 2002 Sep; 277(36):32473-9. PubMed ID: 12080053
[TBL] [Abstract][Full Text] [Related]
9. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
[TBL] [Abstract][Full Text] [Related]
10. Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides.
Rogers FA; Manoharan M; Rabinovitch P; Ward DC; Glazer PM
Nucleic Acids Res; 2004; 32(22):6595-604. PubMed ID: 15602001
[TBL] [Abstract][Full Text] [Related]
11. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide.
Chan PP; Lin M; Faruqi AF; Powell J; Seidman MM; Glazer PM
J Biol Chem; 1999 Apr; 274(17):11541-8. PubMed ID: 10206960
[TBL] [Abstract][Full Text] [Related]
12. Ligand-mediated transcription elongation control using triplex-based padlock oligonucleotides.
Bello-Roufaï M; Roulon T; Escudé C
Chem Biol; 2004 Apr; 11(4):509-16. PubMed ID: 15123245
[TBL] [Abstract][Full Text] [Related]
13. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
Rogers FA; Lloyd JA; Tiwari MK
Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene knockout mediated by triple helix forming oligonucleotides.
Majumdar A; Khorlin A; Dyatkina N; Lin FL; Powell J; Liu J; Fei Z; Khripine Y; Watanabe KA; George J; Glazer PM; Seidman MM
Nat Genet; 1998 Oct; 20(2):212-4. PubMed ID: 9771719
[TBL] [Abstract][Full Text] [Related]
15. Psoralen photo-cross-linking by triplex-forming oligonucleotides at multiple sites in the human rhodopsin gene.
Perkins BD; Wensel TG; Vasquez KM; Wilson JH
Biochemistry; 1999 Sep; 38(39):12850-9. PubMed ID: 10504255
[TBL] [Abstract][Full Text] [Related]
16. Modulation of psoralen DNA crosslinking kinetics associated with a triplex-forming oligonucleotide.
Oh DH; Suzara V; Krishnan R
Photochem Photobiol; 2008; 84(3):727-33. PubMed ID: 18435621
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transcription by platinated triplex-forming oligonucleotides.
Graham MK; Miller PS
J Biol Inorg Chem; 2012 Dec; 17(8):1197-208. PubMed ID: 22965663
[TBL] [Abstract][Full Text] [Related]
18. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei.
Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD
Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133
[TBL] [Abstract][Full Text] [Related]
19. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
Taniguchi Y; Sasaki S
Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
[TBL] [Abstract][Full Text] [Related]
20. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.
Shen C; Rattat D; Buck A; Mehrke G; Polat B; Ribbert H; Schirrmeister H; Mahren B; Matuschek C; Reske SN
Cancer Biother Radiopharm; 2003 Feb; 18(1):17-26. PubMed ID: 12667305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
